These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8611406)

  • 1. P53 expression, DNA ploidy and S-phase cell fraction in operable locally advanced non-small-cell lung cancer.
    Costa A; Silvestrini R; Mochen C; Lequaglie C; Boracchi P; Faranda A; Vessecchia G; Ravasi G
    Br J Cancer; 1996 Apr; 73(7):914-9. PubMed ID: 8611406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.
    Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Di Carlo L; Semeraro A; Daddi G; Darwish S; Stocchi L; Tofanetti FR; Bellezza G; Sidoni A; Tognellini R; Crinò L; Tonato M
    Tumori; 2008; 94(3):398-405. PubMed ID: 18705409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA aneuploidy, S-phase fraction, nuclear p53 positivity, and survival in non-small-cell lung carcinoma.
    Dalquen P; Moch H; Feichter G; Lehmann M; Solèr M; Stulz P; Jordan P; Torhorst J; Mihatsch MJ; Sauter G
    Virchows Arch; 1997 Sep; 431(3):173-9. PubMed ID: 9334838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis.
    Pelletier MP; Edwardes MD; Michel RP; Halwani F; Morin JE
    Can J Surg; 2001 Jun; 44(3):180-8. PubMed ID: 11407827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric analysis of the DNA content of non-small cell lung cancer. Ploidy as a significant prognostic indicator in squamous cell carcinoma of the lung.
    Sahin AA; Ro JY; el-Naggar AK; Lee JS; Ayala AG; Teague K; Hong WK
    Cancer; 1990 Feb; 65(3):530-7. PubMed ID: 2153432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
    Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
    Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of p53 protein expression and DNA ploidy in surgically treated non-small cell lung carcinomas.
    Mørkve O; Halvorsen OJ; Skjaerven R; Stangeland L; Gulsvik A; Laerum OD
    Anticancer Res; 1993; 13(3):571-8. PubMed ID: 8391242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of biological tumor markers (p53, c-myc, Ki-67 and DNA ploidy) by multiparameter flow cytometry in non-small-cell lung cancer.
    Mørkve O; Halvorsen OJ; Stangeland L; Gulsvik A; Laerum OD
    Int J Cancer; 1992 Dec; 52(6):851-5. PubMed ID: 1334053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
    Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
    Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer.
    Järvinen TA; Holli K; Kuukasjärvi T; Isola JJ
    Br J Cancer; 1998 Jun; 77(12):2267-73. PubMed ID: 9649144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of Deoxyribonucleic acid (DNA) image analysis cytometry and immunohistochemical expression of Ki67 in surgically resected non-small cell lung cancers.
    Maounis NF; Chorti M; Apostolakis E; Ellina E; Blana A; Aggelidou M; Dritsas I; Markidou S
    Cancer Detect Prev; 2006; 30(6):507-14. PubMed ID: 17113721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stratification of the biologic aggressiveness of non-small cell lung cancer using DNA flow cytometry and immunohistochemistry for the retinoblastoma protein.
    Otsuka H; Funai S; Tanaka A; Hara S; Shiozaki H
    Lung Cancer; 2004 Sep; 45(3):307-16. PubMed ID: 15301871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of flow cytometric DNA analysis in non-small-cell lung cancer: rationale of sequential processing of frozen and paraffin-embedded tissue.
    Mugüerza JM; Díez M; Torres AJ; López-Asenjo JA; Picardo AL; Gómez A; Hernando F; Cayón R; Granell J; Balibrea JL
    World J Surg; 1997; 21(3):323-9. PubMed ID: 9015179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
    Garinis GA; Gorgoulis VG; Mariatos G; Zacharatos P; Kotsinas A; Liloglou T; Foukas P; Kanavaros P; Kastrinakis NG; Vassilakopoulos T; Vogiatzi T; Field JK; Kittas C
    J Pathol; 2001 Jan; 193(1):55-65. PubMed ID: 11169516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low levels of p27 in association with deregulated p53-pRb protein status enhance tumor proliferation and chromosomal instability in non-small cell lung carcinomas.
    Tsoli E; Gorgoulis VG; Zacharatos P; Kotsinas A; Mariatos G; Kastrinakis NG; Kokotas S; Kanavaros P; Asimacopoulos P; Bramis J; Kletsas D; Papavassiliou AG; Kittas C
    Mol Med; 2001 Jun; 7(6):418-29. PubMed ID: 11474135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survival.
    Lanza G; Maestri I; Dubini A; Gafa R; Santini A; Ferretti S; Cavazzini L
    Am J Clin Pathol; 1996 May; 105(5):604-12. PubMed ID: 8623770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ evaluation of growth fraction determined by monoclonal antibody Ki-67 and ploidy in surgically resected non-small cell lung cancers.
    Simony J; Pujol JL; Radal M; Ursule E; Michel FB; Pujol H
    Cancer Res; 1990 Jul; 50(14):4382-7. PubMed ID: 2163748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ability of bivariate cytokeratin and deoxyribonucleic acid flow cytometry to determine the biologic aggressiveness of resectable non-small cell lung cancer.
    Otsuka H; Funai S; Azumi T; Hara S; Okuno K; Yasutomi M
    J Thorac Cardiovasc Surg; 2002 Aug; 124(2):293-8. PubMed ID: 12167789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of the surgical treatment of patients with non-small cell lung cancer (NSCLC)--relation to DNA ploidy.
    Gawrychowski J; Lackowska B; Gabriel A
    Eur J Cardiothorac Surg; 2003 Jun; 23(6):870-7; discussion 877. PubMed ID: 12829060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.